Medtech stories we missed this week: Aug. 18, 2017

From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Nemaura inks Oceania distribution deal for SugarBeat patch Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for

Medtech stories we missed this week: May 26, 2017

From Merck’s new licensing agreement to surgical study data being touted, here are medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. The

Masimo increasing display options for Root patient monitor

Masimo announced this week that it is releasing its Root patient monitor with a new supplemental display system called Kite. “Kite showcases the versatility and flexibility of Root,”Joe Kiani, founder and CEO of Masimo, said in a news release. “Our goal is to minimize clinician distraction and maximize focus on the patient and relevant data.” Kite

These big medtech names performed the best in early 2017

Fink Densford, Associate Editor and Chris Newmarker, Managing Editor This year so far has been an especially good one for medical device company stocks. More than four-fifths of the world’s 100 largest medical device companies saw their stock values increase during the first quarter of 2017 – about half enjoyed double-digit percentage increases, according to an analysis

Pages: 1 2 3 4 5 6 7 8

Medtech stocks: the best and worst of Q1 2017

More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017, according to a Medical Design & Outsourcing analysis of how the stocks of our Big 100 companies are faring. The situation suggests that even with the uncertainty around what the

Masimo touts adult EEG sensor

Masimo has announced that its RD SedLine EEG sensor is now available in the U.S. The EEG sensor is meant to be used with Masimo SedLine Brain Function Monitoring and is compatible with the O3 Regional Oximetry offered by Masimo. The SedLine and O3 monitor onto the Masimo Root monitoring platform to help clinicians obtain

Medtech stories we missed this week: March 24, 2017

From companies receiving CE marking to other companies adjusting their distribution deals, here are medtech stories we missed this week but thought were still worth mentioning. 1. Viveve Medical closes public offering Viveve Medical announced that it closed its underwritten public offering of 8,625,00 shares of its common stock, according to a March 22 news release.

Medtech stories we missed this week: March 3, 2017

Several clinical study results were published this week, while other companies reached distribution deals. Here are some medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber